Johnson & Johnson and Pfizer are among leading pharmaceutical companies in the world seeking to further grow their revenue.

Both companies are able to grow its dividend consistently.

J&J has higher return on invested capital and better balance sheet than Pfizer.

Both companies have pipelines of products under development in the next few years.

READ FULL ARTICLE HERE